The putative cognitive enhancer KA-672.HCl is an uncompetitive voltage- dependent NMDA receptor antagonist

NeuroReport

Volumn 9, Issue 18, 1998, Pages 4193-4197

  Lishko, Polina V ^a   Maximyuk, Oleksandr P ^a   Chatterjee, Shyam S ^a,b   Nöldner, Michael ^a,b   Krishtal, Oleg A ^a  

^a BOGOMOLETZ INSTITUTE OF PHYSIOLOGY   (Ukraine)

^b DR WILLMAR SCHWABE GMBH AND CO KG   (Germany)

Author keywords

Alzheimer's disease; Concentration clamp; Dementia; Hippocampal neurons; KA 672.HCl; Neuroprotection; NMDA receptor antagonist

Indexed keywords

AMANTADINE; KETAMINE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; COGNITION; COMPETITIVE INHIBITION; DEMENTIA; DRUG RECEPTOR BINDING; ENHANCER REGION; HIPPOCAMPUS; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION;

EID: 0032556784     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199812210-00035     Document Type: Article

References (21)

1. Bresink I, Benke TA, Collett VJ et al. Br J Pharmacol 119, 195-204 (1996).
2. Francis PT, Sims NR, Procter AW et al. J Neurochem 60, 1589-1604 (1993).
3. Young AB, Greenamyre JT, Albin R et al. Science 241, 981-983 (1988).
4. Klockgether T and Turski L. Ann Neurol 34, 585-593 (1993).
5. Lipton SA. Mol Neurobiol 8, 181-196 (1994).
6. Muller WE, Pergande G, Ushijima H et al. Prog Mol Subcell Biol 16, 44-57 (1996).
7. Foster AC and Fagg GE .Nature 329, 395-396 (1987).
8. Bespalov AYu, Dumpis MA, Piotrovsky LB et al. Eur J Pharmacol 264, 494-496 (1994).
9. Wolf ME and Jeziorski M. Brain Res 613, 291-296 (1993).
10. Kornhuber J, Parsons CG, Hartmann S et al. J Neural Transm Gen Sect 102, 237-246 (1995).
11. Danysz W, Parsons CG, Kornhuber J et al. Neurosci Biobehav Rev 21, 455-468 (1997).
12. Parsons CG, Quack G, Bresink I et al. Neuropharmacology 34, 1239-1258 (1995).
13. Winter JC, Helsley SF and Rabin RA. Pharmacol Biochem Behav 61, 1-5 (1998).
14. Nöldner M, Hauer H, Chatterjee SS et al. Drugs Future 21, 779-781 (1996).
15. Sourgens H. Hörr R, Steinbrede H et al. Pharmacol Toxicol 80 (Suppl. 1), abstr. 50 (1997).
16. Kiskin NI, Tsyndrenko AYa, Dumpis MA et al. NeuroReport 2, 29-32 (1991).
17. Krishtal OA, Marchenko SM and Pidoplichko VI. Neurosci Lett 35, 41-45 (1983).
18. Klusa V, Germane S, Chatterjee SS et al. Eur J Pharm Sci 2, 19 (1994).
19. Chatterjee SS and Nöldner M. Pharmacol Toxicol 80 (Suppl. 1, abstr. 16 (1997).
20. Skupins A, Svirskis S, Nöldner M et al. Pharmacol Toxicol 80 (Suppl. 1), abstr. 48 (1973).
21. Nöldner M and Chatterjee SS. Pharmacol Toxicol 80 (Suppl. 1), abstr. 38 (1997).